Araştırma Makalesi
BibTex RIS Kaynak Göster

Prognostic Significance of Monocyte to High-density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion

Yıl 2022, Cilt: 49 Sayı: 1, 12 - 20, 11.03.2022
https://doi.org/10.5798/dicletip.1085926

Öz

Kaynakça

  • 1.Fefer P, Knudtson ML, Cheema AN, et all. Currentperspectives on coronary chronic total occlusions:the Canadian Multicenter Chronic Total OcclusionsRegistry. J Am Coll Cardiol 2012; 59: 991–7.
  • 2.Jeroudi OM, Alomar ME, Michael TT, et all.Prevalence and management of coronary chronictotal occlusions in a tertiary Veterans Affairshospital. Catheter Cardiovasc Interv 2014; 84:637–43.
  • 3.Stone GW, Kandzari DE, Mehran R, et all.Percutaneous recanalization of chronically occludedcoronary arteries: a consensus document: part I.Circulation 2005; 112:2364–72.

Prognostic Significance of Monocyte to High-density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion

Yıl 2022, Cilt: 49 Sayı: 1, 12 - 20, 11.03.2022
https://doi.org/10.5798/dicletip.1085926

Öz

Objective: Monocyte to high-density lipoprotein ratio (MHR) is a biomarker of inflammatory response. In this study, we investigated the relationship between MHR and mortality in patients with chronic coronary artery occlusion (CTO).
Method: Retrospective observational study including 493 patients over a follow up period of 73 months. Blood samples were taken before cardiac catheterization for coronary angiography.
Results: Median follow-up was 48 months(26-73) . Patients were seperated into two groups: (I) MHR <17.68 (n=278, 95 females) and (II) MHR ≥17.68 (n=215, 45 females). Mortality was considerably higher in MHR II than in MHR I (n=70 vs. n=43; p<0,001). MHR was an independent predictor of mortality (OR: 1.089, 95% [CI]: 1.055-1.124, p<0,001). Lower survival rates were found in MHR II on Kaplan-Meier analyses when compared to that of MHR I (75.223±2.670 vs. 89.220±2.102, p<0,001).
Conclusions: As a simple, easy applicable and universal marker, MHR may be a parameter that predicts mortality risk and survival time in CTO patients.

Kaynakça

  • 1.Fefer P, Knudtson ML, Cheema AN, et all. Currentperspectives on coronary chronic total occlusions:the Canadian Multicenter Chronic Total OcclusionsRegistry. J Am Coll Cardiol 2012; 59: 991–7.
  • 2.Jeroudi OM, Alomar ME, Michael TT, et all.Prevalence and management of coronary chronictotal occlusions in a tertiary Veterans Affairshospital. Catheter Cardiovasc Interv 2014; 84:637–43.
  • 3.Stone GW, Kandzari DE, Mehran R, et all.Percutaneous recanalization of chronically occludedcoronary arteries: a consensus document: part I.Circulation 2005; 112:2364–72.
Toplam 3 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Original Articles
Yazarlar

Muhammed Demir Bu kişi benim

Mehmet Özbek Bu kişi benim

Adem Aktan Bu kişi benim

Tuncay Güzel Bu kişi benim

Burhan Aslan Bu kişi benim

Hakkı Şimşek Bu kişi benim

Yayımlanma Tarihi 11 Mart 2022
Gönderilme Tarihi 4 Ekim 2021
Yayımlandığı Sayı Yıl 2022 Cilt: 49 Sayı: 1

Kaynak Göster

APA Demir, M., Özbek, M., Aktan, A., Güzel, T., vd. (2022). Prognostic Significance of Monocyte to High-density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion. Dicle Medical Journal, 49(1), 12-20. https://doi.org/10.5798/dicletip.1085926
AMA Demir M, Özbek M, Aktan A, Güzel T, Aslan B, Şimşek H. Prognostic Significance of Monocyte to High-density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion. diclemedj. Mart 2022;49(1):12-20. doi:10.5798/dicletip.1085926
Chicago Demir, Muhammed, Mehmet Özbek, Adem Aktan, Tuncay Güzel, Burhan Aslan, ve Hakkı Şimşek. “Prognostic Significance of Monocyte to High-Density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion”. Dicle Medical Journal 49, sy. 1 (Mart 2022): 12-20. https://doi.org/10.5798/dicletip.1085926.
EndNote Demir M, Özbek M, Aktan A, Güzel T, Aslan B, Şimşek H (01 Mart 2022) Prognostic Significance of Monocyte to High-density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion. Dicle Medical Journal 49 1 12–20.
IEEE M. Demir, M. Özbek, A. Aktan, T. Güzel, B. Aslan, ve H. Şimşek, “Prognostic Significance of Monocyte to High-density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion”, diclemedj, c. 49, sy. 1, ss. 12–20, 2022, doi: 10.5798/dicletip.1085926.
ISNAD Demir, Muhammed vd. “Prognostic Significance of Monocyte to High-Density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion”. Dicle Medical Journal 49/1 (Mart 2022), 12-20. https://doi.org/10.5798/dicletip.1085926.
JAMA Demir M, Özbek M, Aktan A, Güzel T, Aslan B, Şimşek H. Prognostic Significance of Monocyte to High-density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion. diclemedj. 2022;49:12–20.
MLA Demir, Muhammed vd. “Prognostic Significance of Monocyte to High-Density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion”. Dicle Medical Journal, c. 49, sy. 1, 2022, ss. 12-20, doi:10.5798/dicletip.1085926.
Vancouver Demir M, Özbek M, Aktan A, Güzel T, Aslan B, Şimşek H. Prognostic Significance of Monocyte to High-density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion. diclemedj. 2022;49(1):12-20.